These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2285537)

  • 1. The effect of immunosuppressive treatment on ANCA.
    Petersen J; Rasmussen N
    APMIS Suppl; 1990; 19():40-1. PubMed ID: 2285537
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination of plasmapheresis with subsequent pulse cyclophosphamide as initial treatment of severe Wegener's granulomatosis.
    Heer A; Schroeder JO; Euler HH
    APMIS Suppl; 1990; 19():66. PubMed ID: 2285546
    [No Abstract]   [Full Text] [Related]  

  • 3. Wegener's granulomatosis presenting with sclerokeratitis diagnosed by antineutrophil cytoplasmic autoantibodies (ANCA).
    Florine CW; Dwyer M; Holland EJ
    Surv Ophthalmol; 1993; 37(5):373-6. PubMed ID: 8484170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANCA related antigens.
    Dolman KM; Goldschmeding R; Sonnenberg A; von dem Borne AE
    APMIS Suppl; 1990; 19():28. PubMed ID: 2285533
    [No Abstract]   [Full Text] [Related]  

  • 5. New perspectives in Wegener's granulomatosis.
    Dreisin RB
    Thorax; 1993 Feb; 48(2):97-9. PubMed ID: 8493642
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and histopathological association of 29kD-ANCA and MPO-ANCA.
    Tervaert JW; Elema JD; Kallenberg CG
    APMIS Suppl; 1990; 19():35. PubMed ID: 2178358
    [No Abstract]   [Full Text] [Related]  

  • 7. Sulfamethoxazole-trimethoprim (SMZ-TMP) as an effective therapy for Wegener's granulomatosis (WG)--three more cases.
    Hoen B; Aymard B; Gerard A; Brunet A; Mertes PM; May T; Canton P; Dureux JB
    APMIS Suppl; 1990; 19():65. PubMed ID: 2285545
    [No Abstract]   [Full Text] [Related]  

  • 8. Negative ANCA in Wegener's granulomatosis.
    Carrie S; Hughes KB; Watson MG
    J Laryngol Otol; 1994 May; 108(5):420-2. PubMed ID: 8035124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis.
    Kerr GS; Fleisher TA; Hallahan CW; Leavitt RY; Fauci AS; Hoffman GS
    Arthritis Rheum; 1993 Mar; 36(3):365-71. PubMed ID: 8452581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progress in the diagnosis of Wegener's granulomatosis].
    Zielonka TM; Chorzelski T; Droszcz W
    Pol Arch Med Wewn; 1991 Aug; 86(2):117-21. PubMed ID: 1775390
    [No Abstract]   [Full Text] [Related]  

  • 11. Current classification and definitions of autoantibodies to neutrophil granulocytes.
    Wiik A
    APMIS Suppl; 1990; 19():24-5. PubMed ID: 2285531
    [No Abstract]   [Full Text] [Related]  

  • 12. Wegener's granulomatosis. A distinct gingival lesion.
    Parsons E; Seymour RA; Macleod RI; Nand N; Ward MK
    J Clin Periodontol; 1992 Jan; 19(1):64-6. PubMed ID: 1732312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulomatosis with polyangitis (Wegener's).
    Takimoto T; Morimura O; Inoue T; Terada H; Abe K
    Thorax; 2012 Jun; 67(6):563-4. PubMed ID: 20671306
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre.
    Tervaert JW; Huitema MG; Hené RJ; Sluiter WJ; The TH; van der Hem GK; Kallenberg CG
    Lancet; 1990 Sep; 336(8717):709-11. PubMed ID: 1975893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience on antineutrophil cytoplasm antibodies and antimyeloperoxidase antibodies in rapidly progressive glomerulonephritis.
    Rollino C; Roccatello D; Coppo R; Menegatti E; Basolo B; Giraudo G; Martina G; Piccoli G
    Contrib Nephrol; 1991; 94():101-6. PubMed ID: 1687269
    [No Abstract]   [Full Text] [Related]  

  • 16. Trimethoprim-sulfamethoxazole for scleritis associated with limited Wegener's granulomatosis: use of histopathology and anti-neutrophil cytoplasmic antibody (ANCA) test.
    Soukiasian SH; Jakobiec FA; Niles JL; Pavan-Langston D
    Cornea; 1993 Mar; 12(2):174-80. PubMed ID: 8500327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
    Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU
    Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overlap of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
    Surendran S; Gundappa C; Gandhi A; Kurien AA; Fernando E
    Saudi J Kidney Dis Transpl; 2017; 28(3):639-644. PubMed ID: 28540906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wegener's granulomatosis and ANCA-associated diseases in 1992.
    Kekow J; Gross WL
    Br J Rheumatol; 1993 Feb; 32(2):150-3. PubMed ID: 8428229
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antineutrophil cytoplasmic antibody (C-ANCA) levels in relation to the treatment of Wegener's granulomatosis].
    Maguchi S; Takizawa M; Miyatake Y; Nakamuru Y; Fukuda S; Inuyama Y
    Nihon Jibiinkoka Gakkai Kaiho; 1995 Jun; 98(6):974-83. PubMed ID: 7629651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.